BLEEDING REDUCTION IN ACUTE AND CHRONIC KIDNEY PATIENTS HAVING SURGERY
(BRACKETS) PILOT TRIAL
- Registry ID
- 2024.BRACKETS-PILOT
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- HAMILTON HEALTH SCIENCES CORPORATION
- Start date
- 2025-06-03
- Last update
- 2024-05-13
Conditions
- SURGERY
- KIDNEY DISEASE
- BLOOD LOSS
Related clinical trials
- A PHASE 3 PROSPECTIVE RANDOMISED CLINICAL TRIAL OF VMX-C001 VS USUAL PHARMACOLOGICAL CARE IN PATIENTS RECEIVING A FXA DIRECT ORAL ANTICOAGULANT (FXA DOAC) WHO REQUIRE URGENT SURGERY OR OTHER INVASIVE PROCEDURE THAT IS ASSOCIATED WITH A HIGH RISK OF BLEEDING, WITH OR WITHOUT PLANNED ADMINISTRATION OF HEPARIN (EQUILIBRIX-S)
- PODOMOUNT-BASKET, A PHASE II, MULTICENTRE, RANDOMISED, 2-ARM PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED BASKET TRIAL TO ASSESS SAFETY, TOLERABILITY, PK, AND EFFICACY OF BI 764198 IN FOUR PROTEINURIC KIDNEY DISEASES
- A PHASE 2A, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF VX-407 IN SUBJECTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE WHO HAVE A SUBSET OF PKD1 GENE VARIANTS
- A RANDOMIZED, DOUBLE-BLIND, MULTI-CENTER, PLACEBO-CONTROLLED, PARALLEL-GROUP PHASE 3 STUDY TO COMPARE THE EFFICACY,
ACCEPTABILITY, AND SAFETY OF TRANEXAMIC ACID ORAL SOLUTION 5% WITH PLACEBO IN THE PREVENTION OF CLINICALLY RELEVANT
BLEEDING EVENTS IN SUBJECTS TREATED WITH DIRECT ORAL ANTICOAGULANTS OR VITAMIN K ANTAGONISTS AND UNDERGOING A SINGLE
OR MULTIPLE TOOTH EXTRACTION
- OPTIMIZING PATIENT-CENTRED OUTCOMES USING OPIOID MINIMIZATION STRATEGIES (OPUS) ANESTHESIA PILOT
TRIAL
- BUPIVACAINE WITH EPINEPHRINE VS SHAM INJECTIONS DURING ENDOSCOPIC SEPTOPLASTY: A DOUBLE BLIND, RANDOMIZED CONTROLLED TRIAL
View on source registry